Teladoc Health (NYSE:TDOC) Trading Up 8.5% - Here's What Happened

Key Points

• Teladoc Health's stock rose **8.5%** on Friday, reaching a high of **$9.39**, with approximately **5.6 million** shares traded, a decline from its usual volume.
• Analysts have mixed opinions, with one research firm upgrading the stock to a **strong-buy** and others maintaining **neutral** or **in-line** ratings, while the average target price is **$9.97**.
• Institutional investors have shown increased interest, with major firms boosting their stakes, contributing to institutional ownership of **76.82%** in the company.

Shares of Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) were up 8.5% on Friday . The stock traded as high as $9.39 and last traded at $9.33. Approximately 5,597,027 shares traded hands during mid-day trading, a decline of 19% from the average daily volume of 6,946,522 shares. The stock had previously closed at $8.60.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on TDOC. Mizuho began coverage on Teladoc Health in a research report on Friday, July 25th. They set a "neutral" rating and a $10.00 target price on the stock. Evercore ISI upped their target price on Teladoc Health from $8.00 to $9.00 and gave the company an "in-line" rating in a research report on Wednesday, October 8th. Citigroup upped their target price on Teladoc Health from $9.50 to $10.50 and gave the company a "neutral" rating in a research report on Tuesday. Zacks Research upgraded Teladoc Health from a "hold" rating to a "strong-buy" rating in a research report on Friday, October 10th. Finally, Weiss Ratings restated a "sell (d-)" rating on shares of Teladoc Health in a research report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Teladoc Health has an average rating of "Hold" and an average target price of $9.97.

Teladoc Health Trading Up 9.5%

The firm has a fifty day simple moving average of $8.07 and a 200-day simple moving average of $7.65. The firm has a market cap of $1.66 billion, a P/E ratio of -7.92 and a beta of 1.90. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.67 and a quick ratio of 2.58.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.27) by $0.08. The business had revenue of $631.90 million for the quarter, compared to analyst estimates of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The company's quarterly revenue was down 1.6% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.38) earnings per share. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. On average, equities research analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Cambridge Investment Research Advisors Inc. boosted its holdings in Teladoc Health by 60.8% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 39,738 shares of the health services provider's stock worth $316,000 after acquiring an additional 15,030 shares in the last quarter. Golden State Wealth Management LLC lifted its holdings in shares of Teladoc Health by 102.6% in the first quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after purchasing an additional 1,690 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Teladoc Health by 18.0% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 17,377 shares of the health services provider's stock valued at $138,000 after purchasing an additional 2,652 shares in the last quarter. Farther Finance Advisors LLC lifted its holdings in shares of Teladoc Health by 424.5% in the second quarter. Farther Finance Advisors LLC now owns 9,960 shares of the health services provider's stock valued at $87,000 after purchasing an additional 8,061 shares in the last quarter. Finally, American Century Companies Inc. lifted its holdings in shares of Teladoc Health by 78.8% in the first quarter. American Century Companies Inc. now owns 375,050 shares of the health services provider's stock valued at $2,985,000 after purchasing an additional 165,332 shares in the last quarter. Institutional investors own 76.82% of the company's stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.